Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Standard

Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis. / Holm, Jesper Grønlund; Sørensen, Jennifer Astrup; Thomsen, Simon Francis.

I: International Journal of Dermatology, Bind 61, Nr. 5, 2022, s. e173-e174.

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Harvard

Holm, JG, Sørensen, JA & Thomsen, SF 2022, 'Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis', International Journal of Dermatology, bind 61, nr. 5, s. e173-e174. https://doi.org/10.1111/ijd.16009

APA

Holm, J. G., Sørensen, J. A., & Thomsen, S. F. (2022). Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis. International Journal of Dermatology, 61(5), e173-e174. https://doi.org/10.1111/ijd.16009

Vancouver

Holm JG, Sørensen JA, Thomsen SF. Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis. International Journal of Dermatology. 2022;61(5):e173-e174. https://doi.org/10.1111/ijd.16009

Author

Holm, Jesper Grønlund ; Sørensen, Jennifer Astrup ; Thomsen, Simon Francis. / Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis. I: International Journal of Dermatology. 2022 ; Bind 61, Nr. 5. s. e173-e174.

Bibtex

@article{ff59a9dd66314f4c8b71b917808ef67f,
title = "Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis",
author = "Holm, {Jesper Gr{\o}nlund} and S{\o}rensen, {Jennifer Astrup} and Thomsen, {Simon Francis}",
year = "2022",
doi = "10.1111/ijd.16009",
language = "English",
volume = "61",
pages = "e173--e174",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis

AU - Holm, Jesper Grønlund

AU - Sørensen, Jennifer Astrup

AU - Thomsen, Simon Francis

PY - 2022

Y1 - 2022

U2 - 10.1111/ijd.16009

DO - 10.1111/ijd.16009

M3 - Comment/debate

C2 - 34813086

AN - SCOPUS:85119653632

VL - 61

SP - e173-e174

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 5

ER -

ID: 286012990